Equities
Health CarePharmaceuticals & Biotechnology
  • Price (USD)59.38
  • Today's Change-0.61 / -1.02%
  • Shares traded4.61m
  • 1 Year change+5.13%
  • Beta1.0726
Data delayed at least 15 minutes, as of Jul 30 2021 21:10 BST.
More ▼
Take Action
Take Action
Add this security to watchlist, portfolio, or create an alert to track market movement

Profile data is unavailable for this security.

About the company

Cardinal Health, Inc. is a healthcare services and products company. The Company operates through two segments: Pharmaceutical and Medical. The Pharmaceutical segment distributes branded and generic pharmaceutical, specialty pharmaceutical, over-the-counter healthcare and consumer products. This segment also operates nuclear pharmacies and cyclotron facilities; provides pharmacy management services to hospitals, as well as medication therapy management and patient outcomes services to hospitals, other healthcare providers and payers, and provides services to healthcare companies. The Medical segment distributes a range of medical, surgical and laboratory products, and provides services to hospitals, ambulatory surgery centers, clinical laboratories and other healthcare providers. This segment also manufactures, sources and develops its own Cardinal Health brand medical and surgical products. It provides post-acute care management and transition services, and software to hospitals.

  • Revenue in USD (TTM)156.57bn
  • Net income in USD1.15bn
  • Incorporated1979
  • Employees48.00k
  • Location
    Cardinal Health Inc7000 Cardinal PlDUBLIN 43017-1091United StatesUSA
  • Phone+1 (614) 757-3033
  • Fax+1 (614) 757-6000
  • Websitehttps://www.cardinalhealth.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Novavax, Inc.919.45m-615.11m13.29bn791.00--12.78--14.45-9.25-9.2514.2014.030.6262--17.991,162,389.00-41.90-58.17-71.99-78.78-----66.90-208.57---38.520.307--2,448.4867.33-215.21--24.49--
Repligen Corporation508.51m99.93m13.51bn1.13k137.88--102.6726.561.781.789.13--------450,802.30--3.03--3.3558.8055.7319.6511.93--11.68----35.5334.39179.8845.0158.57--
BioMarin Pharmaceutical Inc.1.92bn-25.23m14.02bn3.06k--3.32166.027.32-0.13444.2610.2323.140.34220.77284.76626,552.40-0.4504-3.55-0.5073-4.1470.6777.95-1.32-10.713.71-2.040.2025--9.1815.89119.13---9.59--
Novocure Ltd544.83m-4.57m15.93bn1.02k--40.183,222.0729.23-0.052-0.0525.123.830.67014.226.55532,575.80-0.5619-14.20-0.6413-16.7379.5372.62-0.8384-21.468.771.360.5852--40.7271.74218.11--7.82--
PPD Inc5.55bn258.30m16.19bn26.00k63.80--31.302.920.72280.722815.54-1.550.8774--3.26213,536.403.47--5.61--37.07--3.96----1.901.14--16.14--119.79------
Viatris Inc13.76bn-1.73bn17.01bn45.00k--0.79414.481.24-1.50-1.5017.7717.720.30872.314.35305,713.30-3.880.5608-4.680.670836.2140.67-12.561.710.73932.510.53250.003.874.85-4,087.50---4.81--
Incyte Corporation2.70bn478.48m17.01bn1.77k35.616.2332.036.292.172.1712.2812.410.84287.287.221,524,486.0014.920.421118.100.502295.8795.9517.700.55393.90--0.01250.0023.5328.75-166.17--48.44--
Cardinal Health Inc156.57bn1.15bn17.23bn48.00k15.189.658.680.113.913.91533.006.153.6811.0317.653,261,875.002.71-0.14696.59-0.34164.404.950.737-0.04080.6331--0.7896--5.088.32-371.17--4.567.03
Elanco Animal Health Inc3.86bn-572.00m17.25bn9.40k--2.15263.764.47-1.21-1.218.3516.930.28881.564.53410,383.00-4.28---4.77--50.6749.96-14.83-5.240.944-0.06380.4349--6.592.39-924.89--25.44--
EXACT Sciences Corporation1.71bn-864.77m18.54bn4.80k--5.21--10.83-5.47-5.4710.5720.710.30594.878.77356,582.90-15.45-16.06-16.80-17.6475.5374.55-50.52-43.592.34-171.830.384--70.19106.79-910.24--84.98--
BIO-TECHNE Corp847.84m184.12m18.76bn2.30k105.0712.1770.0222.124.594.5921.1139.620.41522.656.16368,625.209.007.779.598.2467.2666.5021.6818.973.3214.450.122240.193.4610.31138.7016.2821.050.157
ICON PLC3.19bn363.86m19.36bn16.07k35.63--44.656.076.836.8359.88--------202,880.50--13.41--19.5028.4233.2511.4413.62--15.52--0.00-0.304812.17-11.146.770.5273--
10X Genomics Inc332.76m-533.14m20.12bn946.00--26.69--60.46-5.03-5.033.206.870.42542.097.54390,564.60-68.16---77.00--81.84---160.22--5.87-532.830.00--21.53---1,636.68------
Catalent Inc3.76bn496.80m20.41bn13.90k40.495.4926.195.432.962.9622.4623.940.47425.734.30270,316.507.033.108.073.5333.2031.5314.825.881.955.670.44180.0022.8911.0725.91-3.9927.00--
Charles River Laboratories Intl. Inc3.04bn375.07m20.45bn18.40k55.249.3633.116.727.377.3759.8343.490.552510.725.28165,295.706.876.688.007.9537.1537.2212.4410.581.534.810.49880.0011.5516.4944.5519.3821.37--
Alnylam Pharmaceuticals, Inc.570.94m-876.35m21.03bn1.45k--22.67--36.84-7.55-7.554.927.890.20631.236.83392,940.80-31.67-35.41-37.28-40.1384.63---153.49-368.564.84-7.300.1714--124.2864.353.14--40.29--
Data as of Jul 30 2021. Currency figures normalised to Cardinal Health Inc's reporting currency: US Dollar USD

Institutional shareholders

38.52%Per cent of shares held by top holders
HolderShares% Held
The Vanguard Group, Inc.as of 31 Mar 202134.80m11.99%
SSgA Funds Management, Inc.as of 31 Mar 202117.49m6.03%
BlackRock Fund Advisorsas of 31 Mar 202116.37m5.64%
Macquarie Investment Management Business Trustas of 31 Mar 202111.03m3.80%
T. Rowe Price Associates, Inc. (Investment Management)as of 31 Mar 20219.65m3.33%
Geode Capital Management LLCas of 31 Mar 20215.35m1.84%
American Century Investment Management, Inc.as of 31 Mar 20215.12m1.77%
Fidelity Management & Research Co. LLCas of 31 Mar 20214.13m1.42%
BlackRock Investment Management (UK) Ltd.as of 31 Mar 20214.04m1.39%
Northern Trust Investments, Inc.(Investment Management)as of 31 Mar 20213.77m1.30%
More ▼
Data from 31 Mar 2021 - 31 Mar 2021Source: FactSet Research Systems Inc.
Refinitiv, an LSEG business
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.